DC
NUVB icon

Diametric Capital’s Nuvation Bio NUVB Stock Holding History

Diametric Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Buy
76,138
+8,511
+13% +$41.6K 0.05% 346
2026
Q1 		$290K Buy
+67,627
New +$377K 0.08% 339
2021
Q2 		– Sell
-19,449
Closed -$203K – 170
2021
Q1 		$203K Buy
+19,449
New +$217K 0.16% 119

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Diametric Capital's NUVB Position: Q2 2026 in Review

Diametric Capital increased its Nuvation Bio (NUVB) stake by 13% in Q2 2026, buying an estimated $41.6K and bringing the position to 76,138 shares worth $432K. The position accounts for 0.05% of the portfolio, ranked #346.

Diametric Capital first reported a position in NUVB in Q1 2021 and has held it in 3 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Diametric Capital held 76,138 shares of Nuvation Bio worth $432K as of Q2 2026.
  • Diametric Capital bought 8,511 Nuvation Bio shares in Q2 2026, an estimated $41.6K.
  • Nuvation Bio made up 0.05% of Diametric Capital's portfolio in Q2 2026, its #346 holding.
  • Diametric Capital first reported a position in Nuvation Bio in Q1 2021 and has held it in 3 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.